Takeda to modify peginesatide medication for treating anemia in CRF patients Affymax.
Affymax, Takeda to modify peginesatide medication for treating anemia in CRF patients Affymax, Inc caverta vs viagra . and Takeda Pharmaceutical Business Limited , today announced that following pre-New Medication Application discussions with the U.S. Food and Medication Administration , the companies will progress with their regulatory technique for the investigational drug, peginesatide, for the treating anemia in persistent renal failure individuals on dialysis in the United States. Morris, ceo of Affymax. Predicated on our meeting with FDA, we believe the data from our completed trials are sufficient for overview of our NDA because of this indication.
Aetna renews contract with WellStar Health System for three years Aetna and WellStar Health System in Marietta, Ga., today they reach an agreement on a three-year contract renewal announced. Under this new contract, Aetna members shall continue to receive covered services, at in-network prices, from WellStar services in the higher Atlanta area. Aetna members also will have the ability to continue receiving protected services from WellStar physicians.